Tuttle Capital Management’s P3 Health Partners PIII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-237
Closed -$490 61
2024
Q3
$490 Hold
237
﹤0.01% 64
2024
Q2
$546 Hold
237
﹤0.01% 63
2024
Q1
$831 Hold
237
0.01% 54
2023
Q4
$1.24K Hold
237
0.01% 50
2023
Q3
$2.02K Hold
237
0.01% 53
2023
Q2
$2.85K Hold
237
0.01% 56
2023
Q1
$951 Buy
+237
New +$14.2K 0.01% 43
2022
Q4
Sell
-209
Closed -$8K 98
2022
Q3
$8K Sell
209
-13
-6% -$3.25K 0.03% 81
2022
Q2
$6K Sell
222
-85
-28% -$23.7K 0.02% 98
2022
Q1
$24K Sell
307
-105
-25% -$31.5K 0.06% 87
2021
Q4
$22K Sell
412
-230
-36% -$110K 0.03% 105
2021
Q3
$62K Sell
642
-2,427
-79% -$1.2M 0.07% 110
2021
Q2
$1.19M Buy
+3,069
New +$1.5M 0.53% 64

Other funds holding PIII

Tuttle Capital Management's PIII Position: Q4 2024 in Review

Tuttle Capital Management sold out of P3 Health Partners (PIII) in Q4 2024, closing a stake of 237 shares — an estimated $490 sold.

Tuttle Capital Management first reported a position in PIII in Q2 2021 and held it in 13 quarters. The position peaked at $1.19M in Q2 2021. 37 funds tracked by Wall St. Rank hold PIII as of Q4 2024.

  • Tuttle Capital Management reported no remaining P3 Health Partners position as of Q4 2024 after selling out during the quarter.
  • Tuttle Capital Management sold 237 P3 Health Partners shares in Q4 2024, an estimated $490.
  • Tuttle Capital Management first reported a position in P3 Health Partners in Q2 2021 and held it in 13 quarters.
  • Tuttle Capital Management's P3 Health Partners position peaked at $1.19M in Q2 2021.
  • 37 funds tracked by Wall St. Rank held P3 Health Partners as of Q4 2024.

Based on Tuttle Capital Management's 13F filing for Q4 2024, filed 14 Jan 2025.